Avidity NanoMedicines
IPOHomepage | Avidity Biosciences
Public · San Diego, United States · Founded 2012
- Headquarters
- San Diego
- Founded
- 2012
- Business Model
- B2B
- Website
- aviditybiosciences.com
- Type
- Public
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Avidity Biosciences is a clinical-stage biopharmaceutical company revolutionizing a new class of targeted RNA therapeutics through its proprietary Antibody Oligonucleotide Conjugate (AOC) platform, which combines the specificity of monoclonal antibodies with the precision of oligonucleotides. Beginning with its muscle disease franchise, the company is advancing programs for myotonic dystrophy type 1, facioscapulohumeral muscular dystrophy, and Duchenne muscular dystrophy aimed at treating the root genetic causes of disease. Novartis completed its acquisition of Avidity Biosciences in February 2026.
Summary
Avidity NanoMedicines is a Biotech company based in San Diego, United States, founded in 2012.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Exit History
Jun 2020
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/avidity-nanomedicines"><img src="https://indexed.vc/api/badge/company/avidity-nanomedicines" alt="Avidity NanoMedicines on Indexed.vc" width="260" height="76" /></a>